+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurology Devices Market 2024-2028

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • TechNavio
  • ID: 4860972
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The neurology devices market is forecasted to grow by USD 7.22 bn during 2023-2028, accelerating at a CAGR of 8.06% during the forecast period. The report on the neurology devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of neurological disorders, growing geriatric population, and increasing funding for neurology and related research.

The neurology devices market is segmented as below:

By End-user

  • Hospitals
  • ASCs
  • Others

By Product

  • Neurostimulation devices
  • Interventional neurology devices
  • Neurosurgery devices
  • Cerebrospinal fluid management devices
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the technological advances in neurology devices as one of the prime reasons driving the neurology devices market growth during the next few years. Also, increasing number of initiatives supporting research related to neurostimulation technology and growing medical tourism in emerging economies will lead to sizable demand in the market.

The report on the neurology devices market covers the following areas:

  • Neurology devices market sizing
  • Neurology devices market forecast
  • Neurology devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurology devices market vendors that include Abbott Laboratories, Allengers Medical Systems Ltd., Becton Dickinson and Company, Boston Scientific Corporation, Cadence Inc., Helius Medical Technologies Inc., Hospital Equipment Manufacturing Co., Integra Lifesciences Corp., Johnson and Johnson Services Inc., LivaNova PLC, Medtronic, MicroPort Scientific Corp., Natus Medical Incorporated, NeuroPace Inc., Nihon Kohden Corp., Stryker Corp., The Magstim Co. Ltd., Zimmer Biomet Holdings Inc., B.Braun SE, Penumbra Inc., and Rapid Medical Ltd.. Also, the neurology devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global neurology devices market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global neurology devices market 2018 - 2022 ($ billion)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 ASCs - Market size and forecast 2023-2028
Exhibit 38: Chart on ASCs - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on ASCs - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on ASCs - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on ASCs - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ billion)
Exhibit 47: Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Neurostimulation devices - Market size and forecast 2023-2028
Exhibit 52: Chart on Neurostimulation devices - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Neurostimulation devices - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Neurostimulation devices - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Neurostimulation devices - Year-over-year growth 2023-2028 (%)
7.4 Interventional neurology devices - Market size and forecast 2023-2028
Exhibit 56: Chart on Interventional neurology devices - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Interventional neurology devices - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Interventional neurology devices - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Interventional neurology devices - Year-over-year growth 2023-2028 (%)
7.5 Neurosurgery devices - Market size and forecast 2023-2028
Exhibit 60: Chart on Neurosurgery devices - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Neurosurgery devices - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Neurosurgery devices - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Neurosurgery devices - Year-over-year growth 2023-2028 (%)
7.6 Cerebrospinal fluid management devices - Market size and forecast 2023-2028
Exhibit 64: Chart on Cerebrospinal fluid management devices - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Cerebrospinal fluid management devices - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Cerebrospinal fluid management devices - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Cerebrospinal fluid management devices - Year-over-year growth 2023-2028 (%)
7.7 Others - Market size and forecast 2023-2028
Exhibit 68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Product
Exhibit 72: Market opportunity by Product ($ billion)
Exhibit 73: Data Table on Market opportunity by Product ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 111: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 123: Abbott Laboratories - Overview
Exhibit 124: Abbott Laboratories - Business segments
Exhibit 125: Abbott Laboratories - Key offerings
Exhibit 126: Abbott Laboratories - Segment focus
12.4 B.Braun SE
Exhibit 127: B.Braun SE - Overview
Exhibit 128: B.Braun SE - Business segments
Exhibit 129: B.Braun SE - Key offerings
Exhibit 130: B.Braun SE - Segment focus
12.5 Becton Dickinson and Company
Exhibit 131: Becton Dickinson and Company - Overview
Exhibit 132: Becton Dickinson and Company - Business segments
Exhibit 133: Becton Dickinson and Company - Key news
Exhibit 134: Becton Dickinson and Company - Key offerings
Exhibit 135: Becton Dickinson and Company - Segment focus
12.6 Boston Scientific Corporation
Exhibit 136: Boston Scientific Corporation - Overview
Exhibit 137: Boston Scientific Corporation - Business segments
Exhibit 138: Boston Scientific Corporation - Key news
Exhibit 139: Boston Scientific Corporation - Key offerings
Exhibit 140: Boston Scientific Corporation - Segment focus
12.7 Cadence Inc.
Exhibit 141: Cadence Inc. - Overview
Exhibit 142: Cadence Inc. - Product/Service
Exhibit 143: Cadence Inc. - Key offerings
12.8 Integra Lifesciences Corp.
Exhibit 144: Integra Lifesciences Corp. - Overview
Exhibit 145: Integra Lifesciences Corp. - Business segments
Exhibit 146: Integra Lifesciences Corp. - Key news
Exhibit 147: Integra Lifesciences Corp. - Key offerings
Exhibit 148: Integra Lifesciences Corp. - Segment focus
12.9 Johnson and Johnson Services Inc.
Exhibit 149: Johnson and Johnson Services Inc. - Overview
Exhibit 150: Johnson and Johnson Services Inc. - Business segments
Exhibit 151: Johnson and Johnson Services Inc. - Key news
Exhibit 152: Johnson and Johnson Services Inc. - Key offerings
Exhibit 153: Johnson and Johnson Services Inc. - Segment focus
12.10 LivaNova PLC
Exhibit 154: LivaNova PLC - Overview
Exhibit 155: LivaNova PLC - Business segments
Exhibit 156: LivaNova PLC - Key news
Exhibit 157: LivaNova PLC - Key offerings
Exhibit 158: LivaNova PLC - Segment focus
12.11 Medtronic
Exhibit 159: Medtronic - Overview
Exhibit 160: Medtronic - Business segments
Exhibit 161: Medtronic - Key news
Exhibit 162: Medtronic - Key offerings
Exhibit 163: Medtronic - Segment focus
12.12 MicroPort Scientific Corp.
Exhibit 164: MicroPort Scientific Corp. - Overview
Exhibit 165: MicroPort Scientific Corp. - Business segments
Exhibit 166: MicroPort Scientific Corp. - Key offerings
Exhibit 167: MicroPort Scientific Corp. - Segment focus
12.13 Natus Medical Incorporated
Exhibit 168: Natus Medical Incorporated - Overview
Exhibit 169: Natus Medical Incorporated - Product/Service
Exhibit 170: Natus Medical Incorporated - Key news
Exhibit 171: Natus Medical Incorporated - Key offerings
12.14 Nihon Kohden Corp.
Exhibit 172: Nihon Kohden Corp. - Overview
Exhibit 173: Nihon Kohden Corp. - Product/Service
Exhibit 174: Nihon Kohden Corp. - Key news
Exhibit 175: Nihon Kohden Corp. - Key offerings
12.15 Penumbra Inc.
Exhibit 176: Penumbra Inc. - Overview
Exhibit 177: Penumbra Inc. - Product/Service
Exhibit 178: Penumbra Inc. - Key news
Exhibit 179: Penumbra Inc. - Key offerings
12.16 Stryker Corp.
Exhibit 180: Stryker Corp. - Overview
Exhibit 181: Stryker Corp. - Business segments
Exhibit 182: Stryker Corp. - Key news
Exhibit 183: Stryker Corp. - Key offerings
Exhibit 184: Stryker Corp. - Segment focus
12.17 Zimmer Biomet Holdings Inc.
Exhibit 185: Zimmer Biomet Holdings Inc. - Overview
Exhibit 186: Zimmer Biomet Holdings Inc. - Business segments
Exhibit 187: Zimmer Biomet Holdings Inc. - Key news
Exhibit 188: Zimmer Biomet Holdings Inc. - Key offerings
Exhibit 189: Zimmer Biomet Holdings Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 190: Inclusions checklist
Exhibit 191: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 192: Currency conversion rates for US$
13.4 Research methodology
Exhibit 193: Research methodology
Exhibit 194: Validation techniques employed for market sizing
Exhibit 195: Information sources
13.5 List of abbreviations
Exhibit 196: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global neurology devices market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on End-user - Market share 2023-2028 (%)
Exhibits 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on ASCs - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on ASCs - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on ASCs - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on ASCs - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by End-user ($ billion)
Exhibits 47: Data Table on Market opportunity by End-user ($ billion)
Exhibits 48: Chart on Product - Market share 2023-2028 (%)
Exhibits 49: Data Table on Product - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Product
Exhibits 51: Data Table on Comparison by Product
Exhibits 52: Chart on Neurostimulation devices - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Neurostimulation devices - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Neurostimulation devices - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Neurostimulation devices - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Interventional neurology devices - Market size and forecast 2023-2028 ($ billion)
Exhibits 57: Data Table on Interventional neurology devices - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Chart on Interventional neurology devices - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Interventional neurology devices - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Neurosurgery devices - Market size and forecast 2023-2028 ($ billion)
Exhibits 61: Data Table on Neurosurgery devices - Market size and forecast 2023-2028 ($ billion)
Exhibits 62: Chart on Neurosurgery devices - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Neurosurgery devices - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Cerebrospinal fluid management devices - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Data Table on Cerebrospinal fluid management devices - Market size and forecast 2023-2028 ($ billion)
Exhibits 66: Chart on Cerebrospinal fluid management devices - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Cerebrospinal fluid management devices - Year-over-year growth 2023-2028 (%)
Exhibits 68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 70: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 72: Market opportunity by Product ($ billion)
Exhibits 73: Data Table on Market opportunity by Product ($ billion)
Exhibits 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 77: Chart on Geographic comparison
Exhibits 78: Data Table on Geographic comparison
Exhibits 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 111: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 112: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 113: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 114: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 115: Market opportunity By Geographical Landscape ($ billion)
Exhibits 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 117: Impact of drivers and challenges in 2023 and 2028
Exhibits 118: Overview on Criticality of inputs and Factors of differentiation
Exhibits 119: Overview on factors of disruption
Exhibits 120: Impact of key risks on business
Exhibits 121: Vendors covered
Exhibits 122: Matrix on vendor position and classification
Exhibits 123: Abbott Laboratories - Overview
Exhibits 124: Abbott Laboratories - Business segments
Exhibits 125: Abbott Laboratories - Key offerings
Exhibits 126: Abbott Laboratories - Segment focus
Exhibits 127: B.Braun SE - Overview
Exhibits 128: B.Braun SE - Business segments
Exhibits 129: B.Braun SE - Key offerings
Exhibits 130: B.Braun SE - Segment focus
Exhibits 131: Becton Dickinson and Company - Overview
Exhibits 132: Becton Dickinson and Company - Business segments
Exhibits 133: Becton Dickinson and Company - Key news
Exhibits 134: Becton Dickinson and Company - Key offerings
Exhibits 135: Becton Dickinson and Company - Segment focus
Exhibits 136: Boston Scientific Corporation - Overview
Exhibits 137: Boston Scientific Corporation - Business segments
Exhibits 138: Boston Scientific Corporation - Key news
Exhibits 139: Boston Scientific Corporation - Key offerings
Exhibits 140: Boston Scientific Corporation - Segment focus
Exhibits 141: Cadence Inc. - Overview
Exhibits 142: Cadence Inc. - Product/Service
Exhibits 143: Cadence Inc. - Key offerings
Exhibits 144: Integra Lifesciences Corp. - Overview
Exhibits 145: Integra Lifesciences Corp. - Business segments
Exhibits 146: Integra Lifesciences Corp. - Key news
Exhibits 147: Integra Lifesciences Corp. - Key offerings
Exhibits 148: Integra Lifesciences Corp. - Segment focus
Exhibits 149: Johnson and Johnson Services Inc. - Overview
Exhibits 150: Johnson and Johnson Services Inc. - Business segments
Exhibits 151: Johnson and Johnson Services Inc. - Key news
Exhibits 152: Johnson and Johnson Services Inc. - Key offerings
Exhibits 153: Johnson and Johnson Services Inc. - Segment focus
Exhibits 154: LivaNova PLC - Overview
Exhibits 155: LivaNova PLC - Business segments
Exhibits 156: LivaNova PLC - Key news
Exhibits 157: LivaNova PLC - Key offerings
Exhibits 158: LivaNova PLC - Segment focus
Exhibits 159: Medtronic - Overview
Exhibits 160: Medtronic - Business segments
Exhibits 161: Medtronic - Key news
Exhibits 162: Medtronic - Key offerings
Exhibits 163: Medtronic - Segment focus
Exhibits 164: MicroPort Scientific Corp. - Overview
Exhibits 165: MicroPort Scientific Corp. - Business segments
Exhibits 166: MicroPort Scientific Corp. - Key offerings
Exhibits 167: MicroPort Scientific Corp. - Segment focus
Exhibits 168: Natus Medical Incorporated - Overview
Exhibits 169: Natus Medical Incorporated - Product/Service
Exhibits 170: Natus Medical Incorporated - Key news
Exhibits 171: Natus Medical Incorporated - Key offerings
Exhibits 172: Nihon Kohden Corp. - Overview
Exhibits 173: Nihon Kohden Corp. - Product/Service
Exhibits 174: Nihon Kohden Corp. - Key news
Exhibits 175: Nihon Kohden Corp. - Key offerings
Exhibits 176: Penumbra Inc. - Overview
Exhibits 177: Penumbra Inc. - Product/Service
Exhibits 178: Penumbra Inc. - Key news
Exhibits 179: Penumbra Inc. - Key offerings
Exhibits 180: Stryker Corp. - Overview
Exhibits 181: Stryker Corp. - Business segments
Exhibits 182: Stryker Corp. - Key news
Exhibits 183: Stryker Corp. - Key offerings
Exhibits 184: Stryker Corp. - Segment focus
Exhibits 185: Zimmer Biomet Holdings Inc. - Overview
Exhibits 186: Zimmer Biomet Holdings Inc. - Business segments
Exhibits 187: Zimmer Biomet Holdings Inc. - Key news
Exhibits 188: Zimmer Biomet Holdings Inc. - Key offerings
Exhibits 189: Zimmer Biomet Holdings Inc. - Segment focus
Exhibits 190: Inclusions checklist
Exhibits 191: Exclusions checklist
Exhibits 192: Currency conversion rates for US$
Exhibits 193: Research methodology
Exhibits 194: Validation techniques employed for market sizing
Exhibits 195: Information sources
Exhibits 196: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global neurology devices market: Abbott Laboratories, Allengers Medical Systems Ltd., Becton Dickinson and Company, Boston Scientific Corporation, Cadence Inc., Helius Medical Technologies Inc., Hospital Equipment Manufacturing Co., Integra Lifesciences Corp., Johnson and Johnson Services Inc., LivaNova PLC, Medtronic, MicroPort Scientific Corp., Natus Medical Incorporated, NeuroPace Inc., Nihon Kohden Corp., Stryker Corp., The Magstim Co. Ltd., Zimmer Biomet Holdings Inc., B.Braun SE, Penumbra Inc., and Rapid Medical Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is technological advances in neurology devices.'

According to the report, one of the major drivers for this market is the increasing prevalence of neurological disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Allengers Medical Systems Ltd.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cadence Inc.
  • Helius Medical Technologies Inc.
  • Hospital Equipment Manufacturing Co.
  • Integra Lifesciences Corp.
  • Johnson and Johnson Services Inc.
  • LivaNova PLC
  • Medtronic
  • MicroPort Scientific Corp.
  • Natus Medical Incorporated
  • NeuroPace Inc.
  • Nihon Kohden Corp.
  • Stryker Corp.
  • The Magstim Co. Ltd.
  • Zimmer Biomet Holdings Inc.
  • B.Braun SE
  • Penumbra Inc.
  • Rapid Medical Ltd.